Ministry Aligns Drug Policy With EU Rules
Health authorities are moving to bring national narcotics legislation in line with European Union standards under a multi-year reform program.
Updated on Nov. 8, 2026 in Substance Abuse
Live Poll
Do you think the government is doing enough to protect people from dangerous new drugs?
The Ministry of Health has announced measures to align drug policy with EU legislation under the 2024-2027 Reform Agenda. A working group has been formed to harmonize the Law on the Control of Narcotic Drugs and Psychotropic Substances with EU rules.
Why it matters
The effort ties national drug law to the European framework, with a working agreement with the EU Agency for Drugs in progress. The changes shape how substances are controlled and how drug-related risks are monitored.
The reform is scheduled across the 2024-2027 period, with the second step aligning the psychoactive substance list with the EU list slated for next year. The source does not state how many substances will be affected or when the revised law will take effect.
The players
Ministry of Health
The national ministry responsible for implementing the country's drug policy measures and coordinating alignment with EU law.
European Commission
The executive body of the European Union that approved the TAIEX expert mission to support drafting of the National Drug Strategy.
EU Agency for Drugs (EUDA)
The European agency that monitors drug trends and is the body with which a working agreement is being concluded.
The details
With European Commission approval of a TAIEX expert mission, EU experts will help draft a National Drug Strategy in line with the relevant EU strategy. The mission also provides for strengthening the National Drug Observatory and establishing an early warning system with reporting to the EU Agency for Drugs.
Timeline
2024-2027: Reform Agenda implementation period.
November 8, 2026: Minister announced the measures at a Reform Agenda coordination meeting.
Next year (2027): Planned second step to align substance lists with the EU.
Big Picture
The move follows the EU's own drug strategy framework and the EUDA's reporting structure, extending that model into national legislation. It mirrors how candidate and partner states have aligned their drug laws with EU standards in recent years.
Changes to controlled-substance lists and early warning reporting could affect how new drugs are scheduled and how quickly health risks are flagged. Individuals who use or are treated for substance-related problems may see shifts in availability and regulation over the coming years.
The takeaway
Drug policy alignment with EU frameworks typically strengthens monitoring and early warning systems, which can help authorities respond faster to emerging substances. Readers tracking substance-use policy should watch the second reform step scheduled for next year.
What happens next
The second step of the Reform Agenda is planned for next year to align the list of psychoactive substances with the EU list and incorporate the concept of a new psychoactive substance into legislation.
Further reading
For broader background, see Substance Abuse coverage.
Source note: This article includes information reported by Albeu.com - Lajmet e fundit dhe jo vetëm!.
Live Poll
Do you think the government is doing enough to protect people from dangerous new drugs?
